Hyperfine and Penn Medicine Announce Partnership

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

Hyperfine reports Penn Medicine is among the very first medical centers to use this FDA 510(k)-pending system. In addition to assessing the feasibility of imaging patients with the new device, the Penn Medicine team will be evaluating the Hyperfine system’s diagnostic performance compared to current high field MRI machines and computed tomography (CT) scanners.

Hydrocephalus is a medical condition in which an abnormal buildup of cerebrospinal fluid (CSF) causes the fluid-filled spaces of the brain to become enlarged. This can lead to headaches, dizziness, cognitive impairment, gait disturbances, and in severe cases, even brain herniation or death.

“To treat this condition, an intracranial tube or shunt may be inserted to drain the CSF. Sometimes shunts need to be adjusted or replaced, which requires routine clinical CT or MRI for monitoring,” said Joel Stein, MD, Ph.D., a neuroradiologist and Assistant Professor of Radiology in the Perelman School of Medicine at the University of Pennsylvania. “We want to see if this kind of device can provide a simple, safe and cost-effective way to follow such patients in a physician’s office. Due to the lack of ionizing radiation and open design, it may be particularly useful for children as well as older people.”

The Hyperfine point-of-care (POC) device represents multiple innovations in MRI design, architecture and workflow. It is highly portable and wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled via an iPad®. Hyperfine’s system was developed over the last five years with the goal of making MRI accessible anytime, anywhere, to any patient.

“Hyperfine was founded to increase access to MRI, to move MRI directly to the frontlines of clinical care. Along the way, we have overcome many engineering, physics, and design challenges, and now, together with Penn Medicine, we are excited and honored to see how these efforts can translate to innovative care and greater access for patients,” said Jonathan Rothberg, Ph.D., founder, and chairman of Hyperfine Research.

Hyperfine is introducing its POC MRI system to the broader radiologist community at the Radiological Society of North America (RSNA) meeting on December 1 through December 5 at McCormick Place in Chicago, IL, Booth 7765 (North Hall). Hyperfine’s device is currently 510(k)-pending and not available for sale in the U.S.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.